Bausch Health Companies Inc logo

BHC - Bausch Health Companies Inc Share Price

C$25.33 0.8  3.4%

Last Trade - 04/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £5.17bn
Enterprise Value £23.23bn
Revenue £6.58bn
Position in Universe 62nd / 2677
Bullish
Bearish
Unlock BHC Revenue
Momentum
Relative Strength (%)
1m +0.56%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -39.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
8,206 10,447 9,674 8,724 8,380 8,601 8,056 8,649 +0.9%
+1,663 -84.9 +22.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Bausch Health Companies Inc revenues decreased less than 1% to $2.01B. Net loss increased from $52M to $152M. Revenues reflect Salix segment increase of 7% to $477M, Poland segment increase of 26% to $73M, United States and Puerto Rico segment increase of 1% to $1.21B, Canada segment increase of 14% to $90M, also reflect U.S. Diversified Products segment decrease of 9% to $288M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BHC Revenue Unlock BHC Revenue

Net Income

BHC Net Income Unlock BHC Revenue

Normalised EPS

BHC Normalised EPS Unlock BHC Revenue

PE Ratio Range

BHC PE Ratio Range Unlock BHC Revenue

Dividend Yield Range

BHC Dividend Yield Range Unlock BHC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BHC EPS Forecasts Unlock BHC Revenue
Profile Summary

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated August 9, 2013
Public Since September 20, 1994
No. of Shareholders: 1,853
No. of Employees: 21,700
Sector Healthcare
Industry Pharmaceuticals
Index S&P/TSX Composite , S&P - Tse 300 Capped ,
Exchange Toronto Stock Exchange
Shares in Issue 354,819,440
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BHC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BHC
Upcoming Events for BHC
Thursday 6th August, 2020
Q2 2020 Bausch Health Companies Inc Earnings Call
Monday 2nd November, 2020 Estimate
Q3 2020 Bausch Health Companies Inc Earnings Release
Frequently Asked Questions for Bausch Health Companies Inc
What is the Bausch Health Companies Inc share price?

As of 04/08/20, shares in Bausch Health Companies Inc are trading at C$25.33, giving the company a market capitalisation of £5.17bn. This share price information is delayed by 15 minutes.

How has the Bausch Health Companies Inc share price performed this year?

Shares in Bausch Health Companies Inc are currently trading at C$25.33 and the price has moved by -19.74% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bausch Health Companies Inc price has moved by -19.84% over the past year.

What are the analyst and broker recommendations for Bausch Health Companies Inc?

Of the analysts with advisory recommendations for Bausch Health Companies Inc, there are there are currently 1 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Bausch Health Companies Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Bausch Health Companies Inc next release its financial results?

Bausch Health Companies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Bausch Health Companies Inc dividend yield?

Bausch Health Companies Inc does not currently pay a dividend.

Does Bausch Health Companies Inc pay a dividend?

Bausch Health Companies Inc does not currently pay a dividend.

When does Bausch Health Companies Inc next pay dividends?

Bausch Health Companies Inc does not currently pay a dividend.

How do I buy Bausch Health Companies Inc shares?

To buy shares in Bausch Health Companies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bausch Health Companies Inc?

Shares in Bausch Health Companies Inc are currently trading at C$25.33, giving the company a market capitalisation of £5.17bn.

Where are Bausch Health Companies Inc shares listed? Where are Bausch Health Companies Inc shares listed?

Here are the trading details for Bausch Health Companies Inc:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: BHC
What kind of share is Bausch Health Companies Inc?

Based on an overall assessment of its quality, value and momentum, Bausch Health Companies Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bausch Health Companies Inc share price forecast 2020?

Shares in Bausch Health Companies Inc are currently priced at C$25.33. At that level they are trading at 35.38% discount to the analyst consensus target price of 0.00.

Analysts covering Bausch Health Companies Inc currently have a consensus Earnings Per Share (EPS) forecast of 3.823 for the next financial year.

How can I tell whether the Bausch Health Companies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bausch Health Companies Inc. Over the past six months, the relative strength of its shares against the market has been -28.05%. At the current price of C$25.33, shares in Bausch Health Companies Inc are trading at -15.26% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bausch Health Companies Inc PE Ratio?

We were not able to find PE ratio data for Bausch Health Companies Inc.

Who are the key directors of Bausch Health Companies Inc?

Bausch Health Companies Inc's management team is headed by:

D. Robert Hale - IND
Thomas Ross - LED
Joseph Papa - CHM
Sarah Kavanagh - IND
Christina Ackermann - EVP
Argeris Karabelas - IND
Thomas Appio - CEX
Paul Herendeen - CFO
Richard De Schutter - IND
William Humphries - CEX
Joseph Gordon - CEX
Mark McKenna - CEX
Who are the major shareholders of Bausch Health Companies Inc?

Here are the top five shareholders of Bausch Health Companies Inc based on the size of their shareholding:

Fidelity Investments Canada ULC Investment Advisor
Percentage owned: 9.3% (33.0m shares)
Paulson & Co. Inc. Hedge Fund
Percentage owned: 7.28% (25.8m shares)
ValueAct Capital Management, L.P. Hedge Fund
Percentage owned: 5.05% (17.9m shares)
Glenview Capital Management, LLC Hedge Fund
Percentage owned: 4.41% (15.6m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 3.78% (13.4m shares)
Similar to BHC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.